Cipla - OAI
FDA Inspections Database

Cipla - OAI

FDA Inspections Database

U.S. FDA inspection classifications and citation records from the official FDA inspection database.

OAI · Official Action Indicated India
  • Total Records 5
  • Latest Inspection 2023-02-17
  • Data Source U.S. FDA
  • Last Updated 2025-05-20

41

All
View

7

NAI
View

29

VAI
View

5

OAI
View
Company Overview

Company

Cipla - OAI

Country

India

Social Profiles

Company Snapshot

Cipla - OAI

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra 400 013

India

www.cipla.com/ corporate.one@cipla.com View on Map
FDA Inspections Timeline (5 records)
2023
17 Feb
Official Action Indicated OAI

Legal Name

Cipla Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2023-02-17

FMD Date

2025-05-20

Fiscal Year

2023

State

Pithampur, District Dhar, India

Location

Pithampur, District Dhar, , India

Inspection Info

Fiscal Year: 2023
Citations: No

2022
26 Aug
Official Action Indicated OAI

Legal Name

Cipla Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2022-08-26

FMD Date

-

Fiscal Year

2022

State

Salcette, India

Location

Salcette, , India

Inspection Info

Fiscal Year: 2022
Citations: Yes

2019
27 Sep
Official Action Indicated OAI

Legal Name

Cipla Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2019-09-27

FMD Date

2020-03-19

Fiscal Year

2019

State

Salcette, India

Location

Salcette, , India

Inspection Info

Fiscal Year: 2019
Citations: Yes

2019
27 Sep
Official Action Indicated OAI

Legal Name

Cipla Limited

Project Area

Monitoring of Marketed Animal Drugs, Feed, and Devices

Product Type

Veterinary

Posted Citations

Yes

Inspection End Date

2019-09-27

FMD Date

2020-03-19

Fiscal Year

2019

State

Salcette, India

Location

Salcette, , India

Inspection Info

Fiscal Year: 2019
Citations: Yes

2014
25 Jun
Official Action Indicated OAI

Legal Name

Cipla Limited

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2014-06-25

FMD Date

-

Fiscal Year

2014

State

Mumbai, India

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

Mumbai, , India

Inspection Info

Fiscal Year: 2014
Citations: Yes

Related Databases
  • FDA Inspections
    41 View
  • EDQM CEP
    100 View
  • KDMF
    0 View
  • Japan DMF
    6 View
  • Eudra GMP
    0 View
Classification Breakdown
5 total
  • OAI (Official Action Indicated)
Official Source

All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.

Visit FDA.gov
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Location

Pithampur, District Dhar, , India

Inspection Info

Fiscal Year: 2023
Citations: No

100% Official Data

Directly from the U.S. FDA inspection database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

FDA inspection data is compiled from publicly available U.S. FDA inspection classification records.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.